AstraZeneca, the latest news from Italy on the vaccine, young women and the very rare risk of thrombosis. “Exclude young women from administering viral vector vaccines, not only from the first but also from the second dose, with even clearer indications”. This is the appeal to the Ema of Chiara Azzari, immunologist and professor of Pediatrics at the University of Florence, commenting on the case of the 18 hospitalized at the San Martino Polyclinic in Genoa operated for a thrombosis and who had received the AstraZeneca vaccine. “The Ema – Azzari reminded Adnkronos Salute – indicated that specific forms of thrombosis are possible, in very rare cases. However, it also indicated that there is a population in which these events are more frequent, namely women young people. So much so that even in Italy vaccination with AstraZeneca for young women is no longer started. There are still people who have already taken the first dose and have to take the second. However, on this we already have scientific data according to which it is possible to ‘interchangeability of vaccines among those currently available “.” I think the EMA should give an even clearer indication – he remarks – saying that not only are viral vector vaccinations not given to young women, given the greater risk, but not not even the second dose is given, offering a different vaccine. It is something that no single doctor can say, but the EMA can say it “.